Has Murray Las received payments from drug or device companies?

Yes. Drug and device makers reported $6,420 in general payments to Murray Las across 537 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Murray Las did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Murray Las come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Murray Las

Endocrinology, Diabetes & Metabolism · Denville, NJNPI 1114003928

Payments from drug & device makers

$6,420in general payments, 2019–2025

Across 537 payments — averaging $11.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
Sanofi-aventis U.S. LLC$826
Lilly USA, LLC$430
Amneal Pharmaceuticals LLC$420
AbbVie$402
Amgen$372
plus $3K from 39 others

What the payments were for

Food & beverage$6,34299%
Education$190%
Gifts$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	132	$1,324
Sanofi-aventis U.S. LLC	69	$826
Lilly USA, LLC	49	$430
Amneal Pharmaceuticals LLC	35	$420
AbbVie(2 entities)	37	$402
Amgen	29	$372
AstraZeneca(2 entities)	26	$367
Abbott	14	$254
Merck	25	$250
Boehringer Ingelheim	17	$231
Medtronic(2 entities)	10	$171
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	9	$136
IBSA Pharma Inc.	9	$118
Bayer	5	$97
Mannkind Corporation	4	$95
Radius Health, Inc.	7	$94
Xeris Pharmaceuticals, Inc.	5	$72
Collegium Pharmaceutical, Inc.	5	$66
Clarus Therapeutics Inc.	5	$62
Otsuka America Pharmaceutical, Inc.	4	$56
Zealand Pharma US, Inc.	3	$45
Insulet Corporation	3	$43
Lifescan, Inc.	3	$40
Regeneron Healthcare Solutions, Inc.	3	$40
Dexcom, Inc.	2	$36
Shire North American Group Inc	2	$29
Antares Pharma, Inc.	2	$28
Acadia Pharmaceuticals Inc	2	$28
Kowa Pharmaceuticals America, Inc.	2	$27
Kaleo, Inc.	2	$27
Amarin Pharma, Inc.	2	$26
Johnson & Johnson	2	$26
Senseonics, Incorporated	1	$22
Valeritas, Inc.	1	$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$15
Amryt Pharma Holdings Ltd	1	$15
GSK	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	1	$14
BD	1	$13
Esperion Therapeutics, Inc.	1	$13
Teva Pharmaceuticals USA, Inc.	1	$13
Vertical Pharmaceuticals, LLC	1	$13
Endo Pharmaceuticals Inc.	1	$12
Biohaven Pharmaceuticals, Inc.	1	$12
Cequr Corporation	1	$10

How this compares

$6,420 in reported general payments places this provider in the 70th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey →

Other endocrinology, diabetes & metabolism in Denville

Barry GertzRahway$903K
Nawras MakhsidaRandolph$882K
Marc SandbergFlemington$567K
Joanne WaldstreicherNew Brunswick$441K
Gregory BaroneCherry Hill$433K
Taher ModarressiPennington$414K
Navtika DesaiHillsborough$408K
Atara SchultzTeaneck$357K
Anthony CannonTurnersville$296K
Sunil AsnaniBrick$295K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →